Category: Zacks Small Cap Research

1525354555695540 / 950 POSTS
By Brian Marckx, CFAOTC:SMLRREAD THE FULL SMLR RESEARCH REPORTQ1 2019 Results: Record Revenue, EPS. Cash Flow Increasing. Infrastructure Investments Based on Demand…Semler Scientific (OTC:SMLR) reported financial results for their first quarter endin ...
By Lisa ThompsonNASDAQ:MOGOREAD THE FULL MOGO RESEARCH REPORTMogo (NASDAQ:MOGO) is a rapidly growing Canadian fintech company with over 800K members that generates revenues from a series of innovative products to help consumers manage ...
By David Bautz, PhDNASDAQ:CFRXREAD THE FULL CFRX RESEARCH REPORTBusiness UpdateAdditional Data Presented for Exebacase Phase 2 TrialOn April 16, 2019, Contrafect Corp. (NASDAQ:CFRX) announced the presentation of new data from the Phase 2 clinical tri ...
NASDAQ:CKPTCheckpoint Therapeutics (NASDAQ:CKPT) will be releasing highly anticipated interim data from its Phase I clinical trial this quarter. The readout will be for CK-301, an anti-PD-L1 antibody, which is expected to include safety and efficacy ...
By John Vandermosten, CFANASDAQ:ACHVAchieve Life Sciences, Inc. (NASDAQ:ACHV) announced that its final enrollee had completed their final visit in the Phase IIb ORCA-1 trial on Wednesday. We expect the company will lock the database and perform analy ...
By Brian Marckx, CFANYSE:VNRXREAD THE FULL VNRX RESEARCH REPORTCapital Markets Day UpdateFollowing reporting of Q4 earnings in mid-March, VolitionRx (NYSE:VNRX) had a spate of news leading up to their ‘Capital Markets Day on April 9th at the New York ...
By Steven Ralston, CFAOTC:ALPEREAD THE FULL ALPE RESEARCH REPORTalpha-En Corp (OTC:ALPE) is a technology development company, primarily focusing on the development of a commercially viable process for the production of high-purity lithium metal and o ...
By David Bautz, PhDNASDAQ:SNGXREAD THE FULL SNGX RESEARCH REPORTBusiness UpdateEnrollment Target Reached for Interim Analysis of SGX942 Phase 3 TrialOn April 18, 2019, Soligenix, Inc. (NASDAQ:SNGX) announced that it has reached the enrollment target ...
By Brian Marckx, CFANASDAQ:BMRAREAD THE FULL BMRA RESEARCH REPORTQ3 2019: Revenue Slows Although Potential Growth Catalysts on the Horizon. Further Pipeline Progress… Biomerica (NASDAQ:BMRA) reported financial results for their fiscal 2019 third quar ...
By John Vandermosten, CFAOTC:GOVXREAD THE LATEST GOVX RESEARCH REPORTGeoVax Labs, Inc. (OTC:GOVX) held its special meeting of stockholders and shareholder vote on April 15, 2019. There was a 97.7% response rate for the issued and outstanding shares, ...
1525354555695540 / 950 POSTS